Netherlands· NL-7b1882683a75
Clarelux 500 microgram/g schuim voor cutaan gebruik in spuitbus
A clobetasol product containing clobetasolpropionaat, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Clobetasol is registered in 16 of 19 countries.
Countries holding a registration under ATC D07AD01 (clobetasol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Clobetasol · ATC D07AD01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CLOBETASOLPROPIONAAT
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- D07AD01
- ATC class
- Clobetasol
- Defined daily dose
- 0.5 mg, T
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id131213//30096
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for clobetasol.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clobetasol · interactions on record
273 records
Same medicine, other countries
Clobetasol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesclobetasol propionateGlenmark Pharmaceuticals Inc., USA
- BelgiumClarelux 500 µg/gPierre Fabre Médicament
- SpainCLARELUX 500 microgramos/g ESPUMA CUTANEA EN ENVASE A PRESION.Pierre Fabre Iberica S.A.
- FinlandClareluxPierre Fabre Medicament
- PolandClareluxPierre Fabre Medicament
- United KingdomClarelux 500micrograms/g foamPierre Fabre Ltd
- CzechiaCLARELUXPIERRE FABRE MEDICAMENT, Lavaur
- CanadaCLOBEX SHAMPOOGALDERMA CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Clarelux, Clobex
- Belgium · Cabesol, Clarelux
- Bulgaria · Дермоват, Инфилеа
- Cyprus · Dermovate, Medodermone
- Czechia · Clarelux, Clobetasol Belupo
- Germany · Clarelux, Clobegalen
- Denmark · Clobetasol Propionate Ifc, Clobetasolpropionat
- Estonia · Dermovate, Dermovate Ointment
- Spain · Clarelux, Clobex
- Finland · Clobex, Dermovat
- France · Cabesol, Clarelux
- United Kingdom (Northern Ireland) · Clarelux, Clobaderm
- Greece · Butavate, Clarelux
- Croatia · Cutibel
- Hungary · Clobex, Closanasol
- Ireland · Dermovate, Dermovate Scalp Application
- Iceland · Clobex, Dermovat
- Italy · Clobecare, Clobesol
- Lithuania · Closanasol, Dermovate
- Luxembourg · Cabesol, Clarelux
- Malta · Clobex, Dermovate
- Norway · Clobex, Dermovat
- Poland · Clarelux, Clobederm
- Portugal · Clarelux, Clobetasol Basi
- Romania · Clobetasol Mk, Clobetazol Atb
- Sweden · Clobetasol Teva, Clobex
- Slovenia · Klobetazol Belupo
- Slovakia · Clarelux, Clobetasol Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c0403ac-d366-49b5-bf94-89deb57b76c1 GET /v1/drugs/8c0403ac-d366-49b5-bf94-89deb57b76c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Schuim voor cutaan gebruik",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h30096_smpc.pdf",
"strength": null,
"atc_label": "Clobetasol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131213",
"excipients": [
"BUTAAN (HEAD-SPACE) (E 943A)",
"CETYLALCOHOL",
"CITROENZUUR 0-WATER (E 330)",
"ETHANOL",
"ISOBUTAAN (HEAD-SPACE) (E 943B)",
"POLYSORBAAT 60 (E 435)",
"PROPAAN (HEAD-SPACE) (E 944)",
"PROPYLEENGLYCOL (E 1520)",
"STEARYLALCOHOL",
"TRIKALIUMCITRAAT 1-WATER (E 332)",
"WATER, GEZUIVERD"
],
"substances": [
"CLOBETASOLPROPIONAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131213.pdf",
"authorised_at": "2023/05/17",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "131213//30096",
"additional_monitoring": "N"
}See everything about clobetasol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.